About Biolinq
Biolinq is a company based in San Diego (United States) founded in 2012 by Jared Tangney.. Biolinq has raised $279.89 million across 15 funding rounds from investors including Cirrus Logic, HHS and Senvest Capital. Biolinq offers products and services including Biowearable Sensors and Sensor Array Platform. Biolinq operates in a competitive market with competitors including Dexcom, Livongo, Senseonics, One Drop and mySugr, among others.
- Headquarter San Diego, United States
- Founders Jared Tangney
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biolinq Incorporated
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$279.89 M (USD)
in 15 rounds
-
Latest Funding Round
$100 M (USD), Series C
Mar 07, 2025
-
Investors
Cirrus Logic
& 24 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biolinq
Biolinq offers a comprehensive portfolio of products and services, including Biowearable Sensors and Sensor Array Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sensors for continuous monitoring of metabolic health analytes.
Platform providing real-time feedback for multiple health insights.
Unlock access to complete
Unlock access to complete
Funding Insights of Biolinq
Biolinq has successfully raised a total of $279.89M across 15 strategic funding rounds. The most recent funding activity was a Series C round of $100 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Series C — $100.0M
-
First Round
First Round
(01 Jan 2014)
- Investors Count 25
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series C - Biolinq | Valuation | Alpha Wave Global | |
| Dec, 2023 | Amount | Series B - Biolinq | Valuation | Alpha Wave Global | |
| Nov, 2021 | Amount | Series B - Biolinq | Valuation | RiverVest Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biolinq
Biolinq has secured backing from 25 investors, including venture fund and institutional investors. Prominent investors backing the company include Cirrus Logic, HHS and Senvest Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on growth-stage companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Healthcare startups are funded by this corporate-backed venture capital entity.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biolinq
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biolinq
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biolinq Comparisons
Competitors of Biolinq
Biolinq operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Senseonics, One Drop and mySugr, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| domain | founded_year | HQ Location |
Provider of smart devices for diabetes management for patients and doctors
|
|
| domain | founded_year | HQ Location |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| domain | founded_year | HQ Location |
Provider of workforce healthcare solutions
|
|
| domain | founded_year | HQ Location |
Gamified apps for diabetes management and therapy are provided.
|
|
| domain | founded_year | HQ Location |
Mobile-based diagnostics for diabetes prevention and management are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biolinq
Frequently Asked Questions about Biolinq
When was Biolinq founded?
Biolinq was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Biolinq located?
Biolinq is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Biolinq?
Richard Yang is the current CEO of Biolinq.
Is Biolinq a funded company?
Biolinq is a funded company, having raised a total of $279.89M across 15 funding rounds to date. The company's 1st funding round was a Series B of $100M, raised on Jan 01, 2014.
What does Biolinq do?
Biolinq was founded in 2012 in San Diego, United States, and operates in the health technology sector. A wearable biosensor platform is developed for diabetes management, featuring a wireless microsensor that tracks metabolism and blood glucose levels continuously. Real-time data is delivered to users via integrated systems, supporting ongoing monitoring without invasive methods. Operations focus on advancing non-invasive glucose sensing technologies.
Who are the top competitors of Biolinq?
Biolinq's top competitors include Dexcom, Senseonics and One Drop.
What products or services does Biolinq offer?
Biolinq offers Biowearable Sensors and Sensor Array Platform.
Who are Biolinq's investors?
Biolinq has 25 investors. Key investors include Cirrus Logic, HHS, Senvest Capital, EoFlow, and AXA Investment Managers.